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d-Limonene is found widely in citrus and many other plant 
species; it is a major constituent of many essential oils and 
is used as a solvent for commercial purposes. With the dis-
covery of its chemotherapeutic properties against cancer, it 
is important to investigate the biological effects of the expo-
sure to d-Limonene and elucidate its, as yet unknown, mech-
anism of action. We reported here that d-Limonene is toxic 
in V79 Chinese hamster cells in a dose-dependent manner. 
Moreover, to determine the cellular target of d-Limonene, 
we performed morphological observations and immuno-
cytochemical analysis and we showed that this drug has a 
direct effect on dividing cells preventing assembly of mitotic 
spindle microtubules. This affects both chromosome segre-
gation and cytokinesis, resulting in aneuploidy that in turn 
can lead to cell death or genomic instability.
Introduction
d-Limonene is a monoterpene found especially in citrus essential 
oils. As well as its commercial use as an ingredient in many 
flavouring products, it is now an environmentally acceptable organic 
solvent for industrial purposes (1). Following oral administration, 
d-Limonene is absorbed rapidly and metabolised to perillic 
acid, dihydroperillic acid, limonene1,2-diol and uroterpenol (2). 
d-Limonene and its metabolites are not genotoxic, when tested in 
Salmonella typhimurium in the presence or absence of S9 fraction 
from rat liver (3). However, it has been found to be toxic per se 
in human lung cells under oxygen conditions similar to ‘in vivo’ 
(1), and it showed genotoxicity at doses between 97 and 1549 mM 
when it is contained in essential oil of flowering plants (3).
d-Limonene has been reported to be tumourigenic in the kidney 
of male rats, although not in female rats or in other species. This can 
be explained by the interaction of d-Limonene and α2µ-globulin, a 
low-molecular-weight protein found in significant quantities only 
in male rats (4). Thus, d-Limonene has been regarded as an animal 
carcinogen that is not expected to be carcinogenic to humans (5), 
leading the International Agency for Research on Cancer to clas-
sify it in the group 3 (not carcinogenic to humans). Interestingly, 
other studies have shown that d-Limonene possesses significant 
chemotherapeutic and chemopreventive properties against a num-
ber of murine cancers during the initiation phase, probably due 
to the monoterpene ability to induce carcinogen-metabolising 
enzymes (6). More recently, it has been reported that d-Limonene 
exhibits chemopreventive efficacy in preclinical hepatocellular 
carcinoma models (7) and essential oils from Lippia alba against 
bleomycin-induced genotoxicity.
In a previous work, we have evaluated the toxicity of several 
terpenes present in a citrus essential oil (α-Pinene, β-Pinene, 
d-Limonene and 3-Carene) that were found in high concentrations 
in actual industrial effluents. d-Limonene resulted not mutagenic 
in S. typhimurium or in V79 Hamster Chinese cells (8), but it is 
capable to induce DNA damage. This ability, evaluated by comet 
assay, may be the result of a direct genotoxicity or an indirect 
effect, i.e. the terpenes capability of inducing reactive oxygen spe-
cies (ROS) (9). Despite the fact that d-Limonene is widely found 
in the environment and exposure both indoors and in the work-
place is common, its mechanism of action is poorly understood.
In this study, in vitro experiments were conducted to better 
explore the target(s) of d-Limonene. We demonstrate that acute 
d-Limonene exposure prevents assembly of mitotic spindle 
microtubules that in turn can affect both chromosome segrega-
tion and cytokinesis leading to cell death or genomic instability.
Materials and Methods
Cell culture
The V79 Chinese hamster cells were routinely cultured in Dulbecco’s modi-
fied Eagle’s medium (Biochrome) supplemented with 5% fetal bovine serum 
(Gibco), penicillin (100 U/ml), streptomycin (100  µg/ml) and fungizone 
(25 µg/µl and maintained at 37°C in a 5% CO2 humidified incubator as previ-
ously reported (10). These cells have a doubling time of 14–16 h.
d-Limonene treatment
d-Limonene (Carlo Erba, CAS: 5989-27-5) was further purified by distillation; 
its purity was verified by gas chromatography in a mass spectrometer detector. 
For cell treatments, d-Limonene was diluted in dimethyl sulfoxide (DMSO; 
Sigma–Aldrich, CAS: 67-68-5); the final concentration of DMSO was < 0.5%.
Clonogenic assay
Cells (300) were plated in six-well plates and 18 h after seeding were exposed 
to increasing doses of d-Limonene (0, 0.1, 0.5, 1.0, 1.5, 2.0 and 2.5 mM) for 
Fig. 1. Cell survival in increasing concentrations of d-Limonene. Data are 
presented as the mean ± SD percentages of three independent experiments.
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1 h in complete medium. After treatment, the cells were washed twice with 
Hank’s salt solution and incubated in fresh medium for 10 days. The colonies 
were then stained with 0.1% methylene blue. Treatments were performed three 
times, and cell survival was expressed as a percentage of untreated cells as in 
the previously reported procedure (11).
Morphological observation
Cells (5.0 × 105), plated on 18 × 18 mm glass coverslips in 60-mm Petri 
dishes, were exposed for 1 h in complete medium to 0, 0.5, 1.0 and 
1.5 mM d-Limonene 18 h after seeding. Cells were then washed twice with 
phosphate-buffered saline (PBS) and incubated in fresh medium for 0, 3, 6, 9, 
12 and 24 h. For morphological analyses, cells were prefixed with methanol 
added to the culture medium at a ratio of 1:1 for 5 min at room temperature, 
fixed with methanol for 7 min and then stained with 2.5% Giemsa. At least 
1000 cells (minimum 1000 to maximum 1200) were examined each time to 
determine abnormal cell frequencies. Three independent experiments were 
performed.
Micronuclei assay using anti-kinetochore antibody
The method used was essentially that described by Degrassi and Tanzarella 
(12) with some modifications. Briefly, 5.0 × 105 cells were plated on 18 × 18 
glass coverslips in 60-mm Petri dishes and exposed to 1.5 mM d-Limonene 
for 1 h, then examined after post-treatment incubation in fresh medium for 
0 and 6 h. The slides were immediately fixed in absolute methanol pre-
cooled to −20°C for 30 min. After rinsing four times in PBS + 1% bovine 
serum albumin (BSA) with 0.1% Triton X-100, the samples were incubated 
overnight at 4°C with anti-kinetochore antibody (Antibodies Incorporated, 
Davies, CA, USA). The samples were washed five times with the same 
washing solution and then incubated for 60 min at 37°C with fluorescein 
isothiocyanate-conjugated goat anti-human IgGs (Sigma) diluted 1:100 
in PBS–BSA. After washing, the preparations were mounted in antifade 
solution containing 2 µg/ml propidium iodide as a counterstaining agent. 
The slides were observed under a Nikon fluorescence photomicroscope 
equipped with a HBO 100W mercury lamp and a suitable filter at ×100 
magnification. Between 100 and 200 micronuclei per experimental point 
were evaluated.
Indirect immunostaining
For the microtubule analysis, cells plated onto glass coverslips, as reported 
above, were exposed for 1 h to 0 and 1.5 mM d-Limonene. Cytochalasin B 
(Sigma), at the most appropriate concentration and treatment time, was used 
as positive control for 16 h to 3 µg/ml. At the end of treatments, cells were 
washed, fixed and then incubated with anti-β tubulin antibody, as previously 
described (13).
Fig. 2. d-Limonene induces nuclear abnormalities such as micronuclei (b), micronuclei with chromosome bridge (c), hyperchromatic nuclei (d), cytoplasm 
thickening (e) and giant multinucleated cell (f). Cells recovered after 3 h (b), 6 h (c and d) and 6 h (e and f) post-treatment with 1.5 mM d-Limonene; untreated 
cells (a). Bars represent 10 µm.
Page 2 of 5








Abnormal mitotic spindle induced by d-Limonene
Image processing
All photomicrographs for morphological observations and immunofluores-
cence analysis were processed using Adobe Photoshop 3.0 LE software.
Results and Discussion
d-Limonene is rapidly absorbed and metabolised to oxygenated 
metabolites in rats and humans (14). However, it has been 
recently demonstrated that the d-Limonene concentrates in 
the breast tissue, while the major active circulating metabolite, 
perillic acid, does not (15). In another study, it was found that 
d-Limonene accumulates in adipose tissue after oral dosing 
in humans (16). Several studies have focused on the effects of 
d-Limonene metabolites in human and mouse models prompting 
us to detect the cellular target(s) of d-Limonene rather than its 
metabolites. To reach this goal, we used purified d-Limonene and 
chose a cellular system that does not metabolise monoterpenes 
having no cytochrome P450 activity (17).
Dose–response experiments showed that increasing con-
centrations of d-Limonene had increasingly toxic effects on 
V79 Chinese hamster cells (Figure  1). Indeed, using clono-
genic assay, we calculated an ID50 of 0.75 mM for d-Limonene 
in V79 cells. In particular, concentrations > 1 mM resulted in 
extensive cell death.
To gain insight into d-Limonene cytotoxicity and its poten-
tial target(s), we chose to use the concentrations of 0.5, 1 and 
1.5 mM, one below and two above the ID50, respectively, for 
further experiments on V79 cells.
Morphological observations performed up to 24 h after treat-
ment with increasing doses of d-Limonene showed cells with 
altered morphology and nuclear abnormalities compared with 
the untreated cells also analyzed for each recovery time inde-
pendently of dose and recovery time. These changes were often 
associated with cytoplasm thickening (Figure 2).
Among the cells with nuclear abnormalities, micronucle-
ated cells were seen with significant frequency compared with 
untreated cells after a recovery of only 6 h following treatment 
with 0.5 mM d-Limonene. In contrast, this frequency decreased 
after 24 h recovery (Figure 3).
Taking into account that micronuclei originate from either 
acentric chromosome fragments or from whole chromosomes 
that are not incorporated into daughter nuclei at the time of cell 
division, our result strongly suggests that d-Limonene most 
likely targets cells entering in mitosis. We next sought to distin-
guish micronuclei caused by chromosome breakage from those 
due to chromosome loss, by using immunofluorescent staining 
of kinetochores. Indeed, micronuclei with acentric fragments, 
that are not expected to contain kinetochore proteins, are kine-
tochore negative, while those containing whole chromosomes 
are kinetochore positive.
Results from indirect immunofluorescence with anti-kine-
tochore antibody showed the ability of d-Limonene to induce 
chromosome loss as most micronuclei (70%) were kinetochore 
positive, compared with 4% of those found in untreated cells. 
As we also noticed a valuable presence of 30% of kinetochore-
negative micronuclei d-Limonene induced (comparable to 96% 
of those found in untreated cells), we cannot exclude that acute 
d-Limonene exposure can also cause chromosome breakages 
most likely due to increase in ROS. However, further experi-
ments are needed to clarify this finding.
It has been extensively demonstrated that lagging chro-
mosomes can generally arise by a malfunction in the mitotic 
spindle apparatus, such as disruption of the microtubules. For 
instance, colchicine, a very well-known antimicrotubule agent, 
Fig. 3.  Frequencies of micronucleated cells during 24 h recovery from 
treatment with increasing concentrations of d-Limonene. Data are presented 
as the mean ± SD percentages of three independent experiments. Statistically 
significant differences versus untreated cells are indicated as *P < 0.01 and 
**P < 0.005, according to the Student’s t-test.
Fig. 4.  Examples of normal (a) and d-Limonene-induced aberrant  
(b) mitotic spindles following indirect immunostaining with β-tubulin 
antibody. DNA was counterstained with propidium iodide. Bars represent 
2 µm. ×100 magnification.
Fig. 5.  Frequencies of binucleated cells during 24 h recovery from treatment 
with increasing concentrations of d-Limonene. Data are presented as the 
mean ± SD percentages of three independent experiments. Statistically 
significant differences versus untreated cells are indicated as *P < 0.01 and 
**P < 0.005, according to the Student’s t-test.
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is a potent kinetochore-positive micronuclei inducer (18). 
Consistently, indirect immunofluorescence with anti-β tubulin 
antibody showed that half of the treated cells had only faintly 
fluorescent spots inside metaphase plates; this probably repre-
sents a failed attempt to nucleate microtubule assembly raising 
the possibility that d-Limonene affects the proper building of 
the mitotic spindle (Figure 4).
Another interesting result of the morphological analysis 
was the occurrence of binucleated cells whose frequency was 
always significantly higher than in untreated cells. The highest 
occurrence of binucleated cells was observed after treatment 
with 1.5 mM d-Limonene and a recovery of 12 h (Figure  5). 
On the other hand, elevated level of multinucleated cells 
24 h post-exposure were scored (data not shown), indicating 
that even binucleated cells underwent to aberrant mitosis. 
Interestingly, these data might suggest that d-Limonene 
excretion is not complete within 24 h post-exposure. However, 
further experiments are necessary to establish the amount of 
d-Limonene excreted over a certain period of time.
Binucleated cells arise from the lack of the contractile ring 
that determines the cytokinesis block. In fact, to obtain binucle-
ated cells for research use, cells are exposed to Cytochalasin 
B. Cytochalasin B is an agent that disrupts microfilaments and 
prevents cytokinesis leading to the production of binucleated 
cells (19).
To further understand the effects of d-Limonene, cells were 
treated with either d-Limonene or Cytochalasin B and then 
incubated with anti-β tubulin antibody. As shown in Figure 6, 
the midbodies in binucleated cells induced by d-Limonene 
appeared to be broken up into scattered grains, whereas those 
in binucleated cells induced by Cytochalasin B were com-
pact, although sometimes present at a distance from the cen-
tre. This finding, which demonstrates that microtubule bundle 
failure in the central spindle results in failed cytokinesis, 
provides evidence that d-Limonene gives rise to binucleated 
cells through a different mechanism from Cytochalasin B. It 
is worthwhile to mention that Cytochalasin B affects normal 
F-actin turnover producing aberrant furrows in late mitosis, 
while no detectable effect on stages of mitosis up to late ana-
phase was found (20).
Taken as a whole, the results reported here demonstrate 
that one cellular target of d-Limonene is the mitotic spindle 
microtubules most likely by causing depolymerisation of 
tubulin in the early stage of mitosis. The direct effect of 
this drug in preventing microtubule assembly affects both 
chromosome segregation and cytokinesis, resulting in 
aneuploidy that in turn can leads to cell death or induction 
of unstable cells, with consequent long-term effects. 
However, further investigation will be necessary for a better 
understanding of d-Limonene mechanism of action. A  first 
step would be to evaluate the destiny of bi-multinucleated 
cells over the time of our study and how d-Limonene affects 
microtubule metabolism. It would be also interesting to 
understand if d-Limonene interacts directly or indirectly with 
the DNA. More importantly, perhaps, would be to evaluate 
the dose response of cells/target tissues, especially using 
prolonged low-dose exposure.
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